The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tumors ( Perez, ...

A group of former leaders from health comms giant Inizio Evoke have come together to launch Flex Marketing, a new agency ...

FLEX MARKETING, a dynamic new independent agency built to modernize the approach to healthcare marketing, officially launches today. Its agile, innovative model is ideally suited to address the ...

Fintech is one of Africa's strongest services-driven industries, with the market projected to reach $3.3 billion by 2025 (Statista, 2024).

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

West Pharmaceutical expects full-year earnings in the range of $6 to $6.20 per share, with revenue in the range of $2.88 billion to $2.91 billion. This story was generated by Automated Insights ( http ...

New Mexico Educational Retirement Board decreased its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) ...

West Pharmaceutical Services (NYSE:WST – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and ...

West Pharmaceutical Services is down 39.2% since the beginning of the year, and at $199.74 per share, it is trading 51.1% below its 52-week high of $408.19 from February 2024.